Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer's Disease

被引:78
作者
Shukla, Pradeep K. [1 ]
Delotterie, David F. [2 ]
Xiao, Jianfeng [2 ]
Pierre, Joseph F. [3 ]
Rao, RadhaKrishna [1 ]
McDonald, Michael P. [2 ,4 ,5 ]
Khan, Mohammad Moshahid [2 ,5 ,6 ,7 ]
机构
[1] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Coll Med, Memphis, TN 38163 USA
[2] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Neurol, Memphis, TN 38163 USA
[3] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pediat, Memphis, TN 38163 USA
[4] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Anat & Neurobiol, Memphis, TN 38163 USA
[5] Univ Tennessee, Hlth Sci Ctr, Neurosci Inst, Memphis, TN 38163 USA
[6] Univ Tennessee, Hlth Sci Ctr, Ctr Muscle Metab & Neuropathol, Div Rehabil Sci, Memphis, TN 38163 USA
[7] Univ Tennessee, Hlth Sci Ctr, Dept Phys Therapy, Coll Hlth Profess, Memphis, TN 38163 USA
关键词
alzheimer’ s disease; gut microbiota; NLRP3; inflammasome; amyloid-beta; neuroinflammation;
D O I
10.3390/cells10040779
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD), a progressive neurodegenerative disorder characterized by memory loss and cognitive decline, is a major cause of death and disability among the older population. Despite decades of scientific research, the underlying etiological triggers are unknown. Recent studies suggested that gut microbiota can influence AD progression; however, potential mechanisms linking the gut microbiota with AD pathogenesis remain obscure. In the present study, we provided a potential mechanistic link between dysbiotic gut microbiota and neuroinflammation associated with AD progression. Using a mouse model of AD, we discovered that unfavorable gut microbiota are correlated with abnormally elevated expression of gut NLRP3 and lead to peripheral inflammasome activation, which in turn exacerbates AD-associated neuroinflammation. To this end, we observe significantly altered gut microbiota compositions in young and old 5xFAD mice compared to age-matched non-transgenic mice. Moreover, 5xFAD mice demonstrated compromised gut barrier function as evident from the loss of tight junction and adherens junction proteins compared to non-transgenic mice. Concurrently, we observed increased expression of NLRP3 inflammasome and IL-1 beta production in the 5xFAD gut. Consistent with our hypothesis, increased gut-microbial-inflammasome activation is positively correlated with enhanced astrogliosis and microglial activation, along with higher expression of NLRP3 inflammasome and IL-1 beta production in the brains of 5xFAD mice. These data indicate that the elevated expression of gut-microbial-inflammasome components may be an important trigger for subsequent downstream activation of inflammatory and potentially cytotoxic mediators, and gastrointestinal NLRP3 may promote NLRP3 inflammasome-mediated neuroinflammation. Thus, modulation of the gut microbiota may be a potential strategy for the treatment of AD-related neurological disorders in genetically susceptible hosts.
引用
收藏
页数:17
相关论文
共 87 条
  • [1] Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches
    Ahmad, Mir Hilal
    Fatima, Mahino
    Mondal, Amal Chandra
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2019, 59 : 6 - 11
  • [2] Inflammasome-Microbiota Interplay in Host Physiologies
    Ayres, Janelle S.
    [J]. CELL HOST & MICROBE, 2013, 14 (05) : 491 - 497
  • [3] Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer's disease during lifespan
    Baeuerl, C.
    Collado, M. C.
    Diaz Cuevas, A.
    Vina, J.
    Perez Martinez, G.
    [J]. LETTERS IN APPLIED MICROBIOLOGY, 2018, 66 (06) : 464 - 471
  • [4] Phylogenetic relationships of butyrate-producing bacteria from the human gut
    Barcenilla, A
    Pryde, SE
    Martin, JC
    Duncan, SH
    Stewart, CS
    Henderson, C
    Flint, HJ
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (04) : 1654 - 1661
  • [5] Intestinal permeability - a new target for disease prevention and therapy
    Bischoff, Stephan C.
    Barbara, Giovanni
    Buurman, Wim
    Ockhuizen, Theo
    Schulzke, Joerg-Dieter
    Serino, Matteo
    Tilg, Herbert
    Watson, Alastair
    Wells, Jerry M.
    [J]. BMC GASTROENTEROLOGY, 2014, 14
  • [6] Regulation of inflammation by microbiota interactions with the host
    Blander, J. Magarian
    Longman, Randy S.
    Iliev, Iliyan D.
    Sonnenberg, Gregory F.
    Artis, David
    [J]. NATURE IMMUNOLOGY, 2017, 18 (08) : 851 - 860
  • [7] Impact of the gut microbiota on inflammation, obesity, and metabolic disease
    Boulange, Claire L.
    Neves, Ana Luisa
    Chilloux, Julien
    Nicholson, Jeremy K.
    Dumas, Marc-Emmanuel
    [J]. GENOME MEDICINE, 2016, 8
  • [8] Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model
    Brandscheid, Carolin
    Schuck, Florian
    Reinhardt, Sven
    Schaefer, Karl-Herbert
    Pietrzik, Claus U.
    Grimm, Marcus
    Hartmann, Tobias
    Schwiertz, Andreas
    Endres, Kristina
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2017, 56 (02) : 775 - 788
  • [9] T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease
    Campos-Acuna, Javier
    Elgueta, Daniela
    Pacheco, Rodrigo
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [10] Carabotti M, 2015, ANN GASTROENTEROL, V28, P203